<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02702245</url>
  </required_header>
  <id_info>
    <org_study_id>Thylakoid OGTT</org_study_id>
    <nct_id>NCT02702245</nct_id>
  </id_info>
  <brief_title>Effects of Two Doses of Thylakoids on OGTT</brief_title>
  <official_title>Thylakoids' Effect on Glucose Homeostasis and Appetite Regulation After an Oral Glucose Tolerance Test in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cross-over intervention study aims to investigate the effect of two doses of thylakoids
      to an oral glucose tolerance test (OGTT) on glucose and insulin homeostasis as well as
      appetite regulating hormones in healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A minimum of twenty healthy volunteers are recruited to participate in an OGTT at three
      different occasions separated by one week. At two of the occasions a green leaf extract,
      thylakoids, is added to a glucose solution; 5 gram or 10 gram in randomized order. The third
      occasion, without added thylakoids, serve as control.

      Blood samples are taken fasting and 15, 30, 45, 60, 90, 120 and 180 minutes after the glucose
      load.

      Blood samples are analysed for p-glucose, p-insulin, p-C-peptide, p-ghrelin, p-CCK and
      p-GLP-1.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>180 minutes, repeated at three occasions</time_frame>
    <description>Measurement of p-glucose, p-insulin and p-C-peptide in repeated blood sampling during three hours after an OGTT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>p-GLP-1</measure>
    <time_frame>180 minutes, repeated at three occasions</time_frame>
    <description>Repeated blood sampling during three hours after an OGTT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>p-ghrelin</measure>
    <time_frame>180 minutes, repeated at three occasions</time_frame>
    <description>Repeated blood sampling during three hours after an OGTT.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>Placebo comparator: Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>OGTT without thylakoids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Thylakoids 5 g</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention type: Dietary supplement. Supplement: thylakoid powder, dose 5 g. Intervention: OGTT at one occasion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Thylakoids 10 g</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention type: Dietary supplement. Supplement: thylakoid powder, dose 10 g. Intervention: OGTT at one occasion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Experimental: Thylakoids 5 g</intervention_name>
    <description>75 g pure glucose + 5 g chloroplast membranes from spinach leaves in a dried powder.</description>
    <arm_group_label>Experimental: Thylakoids 5 g</arm_group_label>
    <other_name>Appethyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Experimental: Thylakoids 10 g</intervention_name>
    <description>75 g pure glucose + 10 g chloroplast membranes from spinach leaves in a dried powder.</description>
    <arm_group_label>Experimental: Thylakoids 10 g</arm_group_label>
    <other_name>Appethyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Comparator: Control</intervention_name>
    <description>75 g pure glucose.</description>
    <arm_group_label>Placebo comparator: Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Adult

          -  Normal-weight and weight stable

          -  Not pregnant or breast-feeding

          -  No use of medication that can affect glucose- and insulin homeostasis (for example
             corticosteroids).

        Exclusion Criteria:

          -  Diabetes,

          -  Impaired glucose tolerance and/or insulin resistance

          -  Anaemia

          -  Use of tobacco or drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva-Lena Stenblom, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lund University, Region Skane</affiliation>
  </overall_official>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2016</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Eva-Lena Stenblom</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

